IPO Boutique

Agios Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Agios Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Agios PharmaceuticalsAGIO - $14.00-$16.00 $18.00 $29.005 million7/24/2014
J.P. Morgan, Goldman Sachs
Co-Manager(s):
Cowen & Co., Leerink Swann
Health Care
Filing(s):

Filed 2013-06-10



Agios Pharmaceuticals Quote & Chart - Click for current quote - AGIO

About Agios Pharmaceuticals (adapted from Agios Pharmaceuticals prospectus):
They are a biopharmaceutical company passionately committed to applying their scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and inborn errors of metabolism which are a subset of orphan genetic metabolic diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "AGIO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved